BridgeBio Pharma, Inc. (BBIO) vs Denali Therapeutics Inc. (DNLI)
Detailed comparison between BridgeBio Pharma, Inc., Denali Therapeutics Inc..Total Return (%)
BridgeBio Pharma, Inc. (BBIO)Denali Therapeutics Inc. (DNLI)
Which stock do you think will perform better?
BridgeBio Pharma, Inc.
BBIO
Denali Therapeutics Inc.
DNLI
| Metric | BridgeBio Pharma, Inc. (BBIO) | Denali Therapeutics Inc. (DNLI) |
|---|---|---|
| Current Price | $64.62 | $17.16 |
| Change | -0.92 (-1.40%) | 0.24 (1.42%) |
| Market Cap | $12.45B | $2.52B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -21.12 | -6.24 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $69.48 | $26.18 |
| 52-Week Low | $22.47 | $10.57 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-4.21 | $-2.92 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BBIO | 21.37% | 80.30% | 175.92% | 39.15% | 134.56% | 134.56% |
| DNLI | 7.59% | -26.38% | -30.50% | -72.42% | -20.00% | -20.00% |